Document Detail

Therapy for urolithiasis with hydroxamic acids. IV. Prevention of infected urinary stone formation with N-(pivaloyl)glycinohydroxamic acid.
MedLine Citation:
PMID:  7028944     Owner:  NLM     Status:  MEDLINE    
With the aim of finding a prospective therapeutic compound with a promising potential for the treatment of urolithiasis, we evaluated the effectiveness of a new potent inhibitor of urease, N-(pivaloyl)glycinohydroxamic acid. The present study revealed that N-(pivaloyl)glycinohydroxamic acid effectively inhibited the alkalinization of urine and the stone formation in vitro and in vivo, due to its strong inhibitory potency against the ureolytic activity of intact Proteus mirabilis. The possibility of the clinical application of this compound in the prevention of struvite stone formation caused by infection of urea-splitting bacteria awaits evaluation of the safety of this compound.
M Satoh; K Munakata; K Kitoh; N Seto; T Kanazawa; H Takeuchi; O Yoshida
Related Documents :
21259444 - 1-(3-biaryloxy-2-oxopropyl)indole-5-carboxylic acids and related compounds as dual inhi...
11168884 - New analogues of bradykinin containing a conformationally restricted dipeptide fragment...
15642414 - Non-thiol farnesyltransferase inhibitors: n-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-...
6802974 - Antiinflammatory agents. 2. syntheses and antiinflammatory activity of substituted 2-am...
12213064 - Selective agonists at group ii metabotropic glutamate receptors: synthesis, stereochemi...
19113804 - Intercalation of single-strand oligonucleotides between nucleolipid anionic membranes: ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of pharmacobio-dynamics     Volume:  4     ISSN:  0386-846X     ISO Abbreviation:  J. Pharmacobio-dyn.     Publication Date:  1981 Jul 
Date Detail:
Created Date:  1982-01-20     Completed Date:  1982-01-20     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  7901854     Medline TA:  J Pharmacobiodyn     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  469-74     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Disease Models, Animal
Hydrogen-Ion Concentration
Hydroxamic Acids / pharmacology,  therapeutic use*
Proteus Infections / complications
Proteus mirabilis / drug effects
Urease / antagonists & inhibitors*
Urinary Calculi / microbiology,  prevention & control*
Urine / analysis
Reg. No./Substance:
0/Hydroxamic Acids; 73912-85-3/N-(pivaloyl)glycinohydroxamic acid; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical significance of gingival fluid measurement by "Periotron".
Next Document:  Disposition of oxprenolol in spontaneously hypertensive rats as determined by an enzyme immunoassay.